Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Investigation of the Effect of the Female Urinary Microbiome on Incontinence

Next Previous
X
Search
Trial Profile

Investigation of the Effect of the Female Urinary Microbiome on Incontinence

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Oct 2021

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Conjugated estrogens (Primary)
  • Indications Nocturia; Overactive bladder; Urinary incontinence
  • Focus Therapeutic Use

    • Most Recent Events

    • 10 Aug 2020 Results assessing whether vaginal Estrogen therapy is associated with increased Lactobacillus in the Urine using pooled analysis from 2 trials (NCT02524769 and NCT02835846) published in the American Journal of Obstetrics and Gynecology
    • 18 May 2020 Results, pooled analysis of two trials (NCT02524769 and NCT02835846) assessing the OAB symptoms relief after vaginal estrogen therapy, presented at the 115th Annual Meeting of the American Urological Association
    • 17 Jan 2019 Status changed from recruiting to completed.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top